Category: Greatbatch Inc.
Sunshine Heart taps ex-Boston Scientific cardiovascular R&D veteran Brian Brown as its new vice president for operations & technology.
Greatbatch says it plans to move some of its U.S. manufacturing operations to plants in Tijuana, Mexico, and from Oregon to Massachusetts.
Greatbatch (NYSE:GB) said today that it's planning to shuffle its manufacturing operation, moving some production from Minnesota, Oregon and Massachusetts to plants in Tijuana, Mexico.
Greatbatch files for European CE Mark for its spinal cord stimulation system, hoping to land marketing approval the treatment of chronic pain of the trunk and limbs.
Greatbatch (NYSE:GB) filed a CE Mark application for its spinal cord stimulation system with German notified body TÜV SÜD America.
Greatbatch files a pre-market approval application for its spinal cord neuromodulation system for treatment of chronic pain of the trunk and limbs.
Greatbatch (NYSE:GB) this week filed a pre-market approval application with the FDA for its spinal cord neuromodulation system.
The neuromodulation system comes from the Frisco, Texas-based company's subsidiary, QiG Group, which hopes to win indication to treat chronic pain of the trunk and limbs.
Greatbatch swings to 3rd-quarter profits and beats Wall Street's earnings expectations, sending share prices up today.
Greatbatch (NYSE:GB) shares are up this morning after the medical device company reported a profitable 3rd quarter and beat Wall Street's expectations for per-share earnings.
Uroplasty fills its chief finance officer spot with the former CFO of Synovis, a company acquired by Baxter.
Uroplasty (NSDQ:UPI) named Brett Reynolds to head its vacant finance chief position, drawing the new executive from his most recent gig as CFO at Baxter- (NYSE:BAX)acquired Synovis Life Technologies.
After releasing Q2 earnings, Texas medical device maker Greatbatch raises per-share guidance for the 2nd time in 2 months.
Texas medical device maker Greatbatch (NYSE:GB) posted a profit in Q2 and nudged its 2013 per-share earnings guidance up for the 2nd time in 2 months. The device maker's Q2's sales eked out a 3% boost over last year's figures and profits were up 10%, according to the financial release.